Contaminants in biotechnologically manufactured L-tryptophan.
The epidemic outbreak of a new disease, the eosinophilia-myalgia syndrome (EMS), was traced back to the intake of L-tryptophan (Trp) of certain lots from a single manufacturer. Since some trace contaminants were related to EMS, it appeared to be necessary to identify and find the origin of most trace contaminants in the EMS related Trp in order to apply this knowledge to a prospective manufacturing practice. Seventeen contaminants were determined in an implicated Trp lot by a single reversed-phase high-performance liquid chromatography run using UV and fluorescence detection. Most of these contaminants were classified as Trp metabolites, non-physiological oxidation or carbonyl condensation compounds of Trp. The amount and the pattern of contaminants were compared with recently manufactured Trp and Trp-containing preparations.
Simat
T
T
Institute of Biochemistry and Food Chemistry, University of Hamburg, Germany.
van Wickern
B
B
Eulitz
K
K
Steinhart
E H
EH
D000447:Aldehydes / Q000737:chemistry; D000818:Animals; D001709:Biotechnology; D002851:Chromatography, High Pressure Liquid; D004340:Drug Contamination; D016603:Eosinophilia-Myalgia Syndrome / Q000139:chemically induced; D010084:Oxidation-Reduction; D014364:Tryptophan / Q000009:adverse effects / Q000737:chemistry / Q000302:isolation & purification*
D000447:Aldehydes; D014364:Tryptophan